DEF: Inception Growth Acquisition Seeks Extension to Complete Business Combination Amid Delisting

Inception Growth Acquisition Limited is seeking stockholder approval to extend the deadline for completing a business combination from June 13, 2025, to October 13, 2025, while also addressing its delisting from Nasdaq.

Summary

• Inception Growth Acquisition Limited is holding an Annual Meeting of Stockholders on June 5, 2025, to vote on several proposals.
• The primary proposals involve amending the company's charter and trust agreement to extend the deadline for completing a business combination from June 13, 2025, to October 13, 2025.
• The extension requires depositing $0.075 per public share into the trust account for each one-month extension, funded by the Sponsor as a loan.
• Stockholders will also vote to elect five directors and to approve a proposal to allow for adjournment of the meeting if necessary.
• The company's securities were delisted from Nasdaq due to non-compliance with listing rules and are now trading on the OTC Markets.
• As of April 30, 2025, the redemption price per public share was approximately $13.18, while the closing price on the OTC Markets on May 8, 2025, was $11.99.
• If the extensions are approved and fully utilized, the redemption price per share at the time of a business combination or liquidation is estimated to be $13.48, assuming no prior redemptions.
• If the proposals are not approved, the company will be required to dissolve and liquidate the trust account, rendering warrants and rights worthless.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the delisting from Nasdaq, the need for another extension, and the potential for liquidation. While the sponsor is providing funding, the overall situation indicates significant challenges and uncertainty.

Positives

• The proposed extension provides additional time for the company to find and complete a suitable business combination.
• The Sponsor is willing to fund the extension by providing loans to the company, demonstrating commitment.
• Stockholders have the right to redeem their shares for a pro rata share of the trust account if they do not wish to participate in the extension.
• If the business combination is completed, the loans from the sponsor will be repaid.

Negatives

• The company's securities have been delisted from Nasdaq, which could limit investor transactions and subject the company to additional trading restrictions.
• The company has already extended the deadline multiple times, suggesting difficulty in finding a suitable business combination.
• If the extensions are not approved, the company will be forced to liquidate, resulting in warrants and rights expiring worthless.
• The closing price of the Public Shares on the OTC Markets on May 8, 2025 was $11.99, lower than the redemption price per Public Share of approximately $13.18 on April 30, 2025.

Risks

• The company may not be able to complete a business combination within the extended timeframe.
• The company's securities being traded on the OTC Markets may face limited liquidity and increased trading restrictions.
• The company may be subject to U.S. foreign investment regulations and review by CFIUS, potentially hindering a business combination with a U.S. target.
• There is a risk that the company could be deemed an unregistered investment company under the Investment Company Act of 1940, leading to liquidation.
• The company cannot assure its stockholders that they will be able to sell their Public Shares in the open market, even if the market price per Public Share is lower than the redemption price.

Future Outlook

The company is seeking to extend the deadline for completing a business combination to October 13, 2025, and believes this will provide additional time to find a suitable target. If the extension is not approved, the company will be required to liquidate.

Management Comments

• The board of directors has determined that it is in the best interests of our stockholders to allow the Company to extend the time to complete a business combination.

Industry Context

This announcement is typical for SPACs approaching their initial business combination deadline. Many SPACs seek extensions to provide more time to identify and complete a merger, especially in a challenging market environment. The delisting from Nasdaq highlights the increasing pressure on SPACs to meet listing requirements and complete deals within the specified timeframe.

Comparison to Industry Standards

• The structure of the extension, requiring a per-share deposit into the trust account, is a common mechanism used by SPACs to incentivize shareholders to remain invested.
• The amount of $0.075 per share per month is within the typical range seen in other SPAC extension votes, although the specific amount varies depending on the size of the trust account and the sponsor's willingness to contribute.
• Comparable companies such as Gores Metropoulos II, Inc. and Churchill Capital Corp IV also sought extensions with similar deposit structures.
• The delisting from Nasdaq is a significant negative event, as it reduces liquidity and investor confidence, similar to what happened with companies like DiamondPeak Holdings Corp after failing to meet listing requirements.

Related Party Transactions

• In March 2021, the Sponsor purchased 2,587,500 founder shares for $25,000.
• Simultaneously with the closing of the IPO, the company consummated the private placement with the Sponsor of an aggregate of 4,721,250 private placement warrants for a purchase price of $1.00 per warrant.
• The company is obligated to pay our Sponsor a monthly fee of $10,000 for general and administrative services.
• As of December 31, 2024 and 2023, we had a temporary advance of $503,946 and $286,007 from our Sponsor, respectively.
• On November 17, 2023, January 24, 2024, March 12, 2024, April 26, 2024 and September 30, 2024, the Company issued five unsecured promissory notes (the Notes) in an amount of $200,000, $420,000, $400,000, $100,000 and $420,000 to the Sponsor, respectively.

Stakeholder Impact

• Shareholders face the risk of dilution if the business combination is completed and the sponsor's loans are converted into equity.
• Shareholders who choose to redeem their shares will receive a pro rata share of the trust account, but will forgo any potential upside from a future business combination.
• If the extensions are not approved, shareholders will receive a pro rata share of the trust account upon liquidation, but warrants and rights will expire worthless.
• Employees and other stakeholders of potential target companies face uncertainty as the company's future depends on completing a business combination.

Next Steps

• Stockholders will vote on the proposed charter and trust agreement amendments at the Annual Meeting on June 5, 2025.
• If approved, the company will have the option to extend the business combination deadline to October 13, 2025, by making monthly deposits into the trust account.
• The company will continue to seek a suitable business combination target.

Key Dates

Keywords

business combination, extension, trust account, redemption, delisting, SPAC, proxy statement, stockholders, IPO, liquidation